Braidwell
Overview
Braidwell is a life science-focused investment firm dedicated to serving the people and organizations that transform human health. The firm provides flexible capital and thoughtful partnership to healthcare companies at all stages of development and across various parts of the capital structure, including public, private, and structured capital markets. Braidwell was co-founded by Alex Karnal, former Co-Portfolio Manager and Managing Director at Deerfield Management, and Brian Kreiter, former Chief Operating Officer of Bridgewater Associates. The team comprises experts across investment research, science, biostatistics, commercial analysis, and financial structuring. Braidwell launched its flagship fund in April 2022 with $3.5 billion of capital and is based in Stamford, Connecticut. Braidwell's investment strategy focuses on providing flexible capital solutions to companies in the biotechnology, pharmaceutical, medical device, and diagnostics industries. The firm engages in investments across various stages, including seed, early stage, growth, late stage, pre-IPO, buyout, turnaround, and distressed situations. Braidwell's portfolio includes notable companies such as Caris Life Sciences, Lila Sciences, Nevro Corp., Bicara Therapeutics, and Tome Biosciences. The firm's approach emphasizes collaboration and partnership, aiming to accelerate the growth and development of its portfolio companies. Braidwell's team leverages its expertise in investment research, science, and financial structuring to support the strategic objectives of its investee companies, contributing to advancements in human health and medical innovation.
Investment Focus
- Companies in biotechnology, pharmaceuticals, medical devices, and diagnostics industries
- All stages of development
- Public, private, and structured capital markets
Portfolio Companies
Reach Braidwell directly
Verified work email, phone and LinkedIn for the full team — one spreadsheet, one payment, yours to keep.
Unlock full contacts →Frequently asked questions about Braidwell
What sectors does Braidwell invest in?
Braidwell invests in Pharmaceuticals, Medical Devices, Diagnostics and Biotechnology, and is based in Connecticut, United States. Braidwell is listed as a private investment firm in the ConnectSafely investor database.
What stage does Braidwell invest at?
Braidwell backs companies at Seed, Early Stage, Growth, Late Stage, Pre-IPO and Buyout, writing cheques of 50M - 200M.
Which regions does Braidwell invest in?
Braidwell invests across United States.
Who are the partners at Braidwell?
Team members listed for Braidwell include Brian Kreiter (Co-Founder and Chief Executive Officer) and Alex Karnal (Co-Founder and Chief Investment Officer).
What companies has Braidwell invested in?
Braidwell's portfolio includes Caris Life Sciences, Bicara Therapeutics, Lila Sciences, Nevro Corp. and Tome Biosciences.
How do I contact Braidwell?
Braidwell's contact details — including LinkedIn — are listed in the ConnectSafely investor database, along with its website and the LinkedIn profiles of its partners.
Last updated · Source: ConnectSafely investor database
